Entest Group, Inc. (ETNI) Stock
Entest Group, Inc. currently lacks substantial active business operations.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Entest Group, Inc.
Entest Group, Inc. currently lacks substantial active business operations. Its primary objective is to identify, scrutinize, and analyze potential business ventures, with the aim of achieving a merger, acquisition, or other form of business consolidation with an existing operating company. Founded in 2008 and based in Shenzhen, China, the company adopted its current name in February 2018, having previously operated as Entest Biomedical, Inc.
Entest Group, Inc. (ETNI) stock trades at $0.00 with a market capitalization of $9834. The stock is valued at a price-to-earnings (P/E) ratio of 0.05, a negative price-to-book of -0.30, reflecting negative shareholders' equity, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades 100.0% below its 52-week high.
On profitability, Entest Group, Inc. generates a return on equity (ROE) of -137.67% (not meaningful, as shareholders' equity is negative), return on capital employed of 122.79%.
Official website: www.entestgroup.com
Related Financial Services Stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.